Merck Discontinues Development of SARS-CoV-2/COVID-19 Vaccine
QuoteKENILWORTH, N.J.--(BUSINESS WIRE)--
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the company is discontinuing development of its SARS-CoV-2/COVID-19 vaccine candidates..